In the news
Aarti Drugs targets 15-16% EBITDA margin on facility ramp-up
Aarti Drugs Q1 profit falls 7% despite 19% revenue growth; leadership transition
Aarti Drugs Q4 profit rises 16% YoY to ₹55 crore, revenue up 20%